Skip to main content

Year: 2023

Verano Launches Savvy Threads, Limited-Edition Streetwear and E-Commerce Platform

Forged at the intersection of cannabis culture, art and fashion, each Savvy Threads piece features Savvy-inspired designs from a variety of graphic artistsThe Savvy Threads store is available on SavvyThreads.com and features a variety of special-edition branded apparel that ships to all 50 United States To create a line of unique, evocative pieces, Verano partnered with artists Mike Frontier and Jacob Wayne of Chicago, and Jeremiah Kaniaupio of Las Vegas Savvy Threads unlocks Verano’s ability to advertise using targeted social media campaigns on Meta’s Instagram and Facebook, and provides Verano access to a larger addressable marketCHICAGO, Oct. 25, 2023 (GLOBE NEWSWIRE) — Verano Holdings Corp. (NEO: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of Savvy...

Continue reading

Provident Financial Holdings Reports First Quarter Fiscal Year 2024 Results

Net Income of $1.76 Million in the September 2023 Quarter Net Interest Margin Unchanged at 2.88% for the Current and Sequential Quarters Loans Held for Investment of $1.07 Billion at September 30, 2023, Down 1% from June 30, 2023 Total Deposits of $931.1 Million at September 30, 2023, Down 2% from June 30, 2023 Non-Performing Assets to Total Assets Ratio of 0.10% at September 30, 2023 Non-Interest Expenses Remain Well Controlled RIVERSIDE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B. (“Bank”), today announced earnings for the first quarter of the fiscal year ending June 30, 2024. For the quarter ended September 30, 2023, the Company reported net income of $1.76 million, or $0.25 per diluted share (on 7.03 million...

Continue reading

Integra LifeSciences Reports Third Quarter 2023 Financial Results

PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2023. Third Quarter 2023 HighlightsThird quarter revenues of $382.4 million declined 0.7% on a reported basis and declined 0.4% on an organic basis compared to the prior year and increased 7.1% on an organic basis excluding BostonThird quarter GAAP earnings per diluted share of $0.24, compared to $0.60 in the prior year; adjusted earnings per diluted share of $0.76, compared to $0.86 in the prior yearSuccessfully completed all interim external inspections in preparation for the Boston manufacturing facility restart and remain on track to committed timelinesRelaunched CereLink® ICP Monitor in select...

Continue reading

Constellium Reports Third Quarter 2023 Results

PARIS, Oct. 25, 2023 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) today reported results for the third quarter ended September 30, 2023. Third quarter 2023 highlights:Shipments of 369 thousand metric tons, down 5% compared to Q3 2022 Revenue of €1.7 billion, down 15% compared to Q3 2022 Value-Added Revenue (VAR) of €704 million, up 5% compared to Q3 2022 Net income of €64 million compared to net income of €131 million in Q3 2022 Adjusted EBITDA of €168 million, up 5% compared to Q3 2022 Cash from Operations of €154 million and Free Cash Flow of €78 millionNine months ended September 30, 2023 highlights:Shipments of 1.2 million metric tons, down 5% compared to YTD 2022 Revenue of €5.6 billion, down 10% compared to YTD 2022 VAR of €2.2 billion, up 11% compared to YTD 2022 Net income of €118 million compared to net income...

Continue reading

Form 8.3 – [EMIS GROUP PLC 24 10 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Fortuna to release third quarter 2023 financial results on November 8, 2023; Conference call at 12 p.m. Eastern time on November 9, 2023

VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) announces that it will release its unaudited financial statements and MD&A for the third quarter 2023 on Wednesday, November 8, 2023, after market close. A conference call to discuss the financial and operational results will be held on Thursday, November 9, 2023, at 9:00 a.m. Pacific time | 12:00 p.m. Eastern time. Hosting the call will be Jorge A. Ganoza, President and CEO, Luis D. Ganoza, Chief Financial Officer, Cesar Velasco, Chief Operating Officer – Latin America, and David Whittle, Chief Operating Officer – West Africa. Shareholders, analysts, media and interested investors are invited to listen to the live conference call by logging onto the webcast at: https://www.webcaster4.com/Webcast/Page/1696/49330...

Continue reading

iQIYI to Report Third Quarter 2023 Financial Results on November 21, 2023

BEIJING, Oct. 25, 2023 (GLOBE NEWSWIRE) — iQIYI, Inc. (NASDAQ: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced that it will report its financial results for the third quarter ended September 30, 2023 before the U.S. market opens on November 21, 2023. iQIYI’s management will hold an earnings conference call at 6:30 AM on November 21, 2023, U.S. Eastern Time (7:30 PM on November 21, 2023, Beijing Time). Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique access PIN by a calendar invite. Participant Online Registration: https://s1.c-conf.com/diamondpass/10034674-abdow7.html It will automatically direct you to the registration...

Continue reading

North Media Q3 2023 Interim Report: Invitation to earnings and investor calls

Investor News 25 October 2023 Following the release of the Q3 2023 interim report on 1 November 2023 North Media will present its financial results on two calls on 2 November 2023. The earnings call will take place on 2 November at 13.00 (CET). On the call, Kåre Wigh, CFO of North Media will comment on the Group’s financial and operational performance and take questions. The earnings call will be conducted in English. Please register and follow the event here. For participation via phone, please use one of the following numbers:Denmark: +45 78 76 84 90Germany: +49 302 178 9327Norway: +47 21 95 63 42Sweden: +46 812 410 952United Kingdom: +44 203 769 6819United States: +1 646 787 0157 (Pin: 363566) The investor call will take place on 2 November at 15.00 (CET).Also at this call, Kåre Wigh will comment on the financial and operational...

Continue reading

Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress

Tokyo, Japan and Cambridge, UK, 25 October 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) will hold an R&D Day on Friday, 10 November 2023, at 4 pm JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event.Date: Friday, 10 November 2023 Time: 4 pm – 5 pm JST (7 am – 8 am GMT)Presenters:  Chris Cargill, President and CEO Corporate presentation, vision, strategy and progress Dr. Matt Barnes, Head of UK R&DProgress in UK R&DDr. Satoshi Tanaka, President of Idorsia Pharmaceuticals JapanDevelopment and Sales in Japan and APACHironoshin Nomura, CFOSupplementary Explanation for Q3FY2023 ResultsQ&AThe R&D Day will be conducted in Japanese and English with simultaneous translation. Archive streaming will be available on the company’s website...

Continue reading

CORRECTION: Resolutions of the Extraordinary General Meeting of BBS-Bioactive Bone Substitutes Plc

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 25 October 2023 at 10.20 pm (EET) CORRECTION: The maximum number of shares was falsely stated in the original release (Resolutions of the EGM) to be 6,000,000 shares. The EGM decided, contrary to the original Notice to the Meeting (published on 28 September 2023), that the maximum number is 7,000,000 million shares. The corrected release is available below in full. Resolutions of the Extraordinary General Meeting of BBS-Bioactive Bone Substitutes Plc BBS-Bioactive Bone Substitutes Plc’s Extraordinary General Meeting (EGM) was held at the company’s premises in Oulu on Monday 23 October 2023 starting at 2.00 pm (EET). The Extraordinary General Meeting authorized the Board of Directors to decide in one or more instalments on share issues and on the issuance of option rights and other...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.